Epirubicin hydrochloride
USP/1237382 - United States Pharmacopeia (USP) Reference Standard
Synonym: 4′-Epidoxorubicin hydrochloride; Epidoxorubicin hydrochloride
CAS Number: 56390-09-1
Empirical Formula (Hill Notation): C27H29NO11 · HCl
Molecular Weight: 579.98
MDL Number: MFCD00941448
Linear Formula: C27H29NO11 · HCl
Product Type: Chemical
API family | epirubicin |
application(s) | pharmaceutical (small molecule) |
format | neat |
grade | pharmaceutical primary standard |
InChI | 1S/C27H29NO11.ClH/c1-10-2 |
InChI key | MWWSFMDVAYGXBV-FGBSZODSSA |
manufacturer/tradename | USP |
SMILES string | Cl.COc1cccc2C(=O)c3c(O)c4 |
storage temp. | −20°C |
Analysis Note: | These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind. |
Application: | Epirubicin hydrochloride USP reference standard, intended for use in specified quality tests and assays as specified in the USP compendia. |
Biochem/physiol Actions: | Cell-permeable anthracycline antitumor antibiotic. Antineoplastic. A stereoisomer of doxorubicin that exhibits reduced cardiotoxicity. Its antitumor actions are mediated by targeting topoisomerase II. |
General description: | This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia ![]() ![]() |
Other Notes: | Sales restrictions may apply. |
Symbol | ![]() ![]() |
Signal word | Danger |
Hazard statements | H302 - H340 - H350 - H360 |
Precautionary statements | P201 - P280 - P301 + P312 + P330 - P308 + P313 |
RIDADR | NONH for all modes of transport |
WGK Germany | WGK 3 |
Flash Point(F) | Not applicable |
Flash Point(C) | Not applicable |
Storage Temp. | −20°C |
UNSPSC | 41116107 |